Patients with schizophrenia not only suffer from severe psychological symptoms, but also have a dramatically increased risk of cardiometabolic diseases. The interplay of disease-associated mechanisms, genetic predispositions and exogenous influences leads to the development of a metabolic syndrome in many patients, which significantly increases morbidity and mortality.
You May Also Like
- Epilepsy
Cannabidiol for refractory epilepsy syndromes
- Stomach cancer and Helicobacter pylori
A question of income?
- Prurigo nodularis and AD
Effective itch relief through inhibition of the IL-31 signaling pathway
- Cutaneous Crohn's disease
Effective alternative to TNF inhibitors
- Palliative care symptom and needs assessment.
What screening tools are helpful?
- Benralizumab in a patient with asthma and EGPA
When the biologic has a counterproductive effect
- Brain atrophy and MS
Brain atrophy correlates with disability progression in MS
- Diabetes mellitus